What do we know about remdesivir drug interactions
2020
: The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) has resulted in a critical need to rapidly develop new pharmacologic interventions and disseminate information. This has led to confusing and conflicting information on drug efficacy. Remdesivir has emerged as a promising treatment for SARS-Co-V-2 infection yet published clinical pharmacology and drug interaction studies are limited. Additional studies of the disposition of remdesivir, its active metabolite (GS-441524), and its triphosphate metabolite (GS-443902) are needed.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
31
Citations
NaN
KQI